Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study

Open access
Joliat, Gaëtan-Romain, Gaspar-Figueiredo, Sérgio, Labgaa, Ismail, Vrochides, Dionisios, Perinel, Julie, Adham, Mustapha, Demartines, Nicolas, Schäfer, Markus · 2023 · Journal of Cancer Research and Clinical Oncology

Abstract

Purpose: Statin treatment has been shown in certain population studies and meta-analyses to improve survival of patients with pancreatic ductal adenocarcinoma (PDAC). This study assessed if patients with statin treatment had better overall survival (OS) and disease-free survival (DFS) after upfront pancreatoduodenectomy for PDAC. Methods: Consecutive PDAC patients were retrospectively collected from three centers in Europe and USA (study period: 2000–2017). Adult patients who underwent upfront pancreatoduodenectomy and survived the first 90 postoperative days were included. Patients with metastasis at diagnosis or with macroscopic incomplete resection were excluded. Patients were considered under statin if started at least one month before pancreatoduodenectomy. Survival rates were calculated using Kaplan–Meier method and compared with log-rank test. Results: A total of 496 patients were included. Median age was 67 years (IQR 59–75), 48% (n = 236) were women, and 141 patients (28%) received statin treatment already preoperatively. Patients with and without statin treatment were comparable in terms of demographics and pre-/intraoperative characteristics, except for age and pre-existing diabetes. Median OS and DFS were similar in patients with and without statin treatment (OS: 29, 95% CI 22–36 vs. 27 months, 95% CI 22–32, p = 0.370, DFS: 18, 95% CI 14–22 vs. 16 months, 95% CI 14–18, p = 0.430). On multivariable Cox regression, lymph node involvement (HR 1.9, 95% CI 1.6–2.2, p < 0.001), tumor differentiation (HR 1.3, 95% CI 1.1–1.6, p = 0.003), and postoperative chemotherapy (HR 0.5, 95% CI 0.4–0.7, p < 0.001) were predictors of OS, whereas statin treatment was not a prognostic factor (HR 0.9, 95% CI 0.7–1.2, p = 0.376). Conclusion: In this international cohort of PDAC patients, statin treatment did not influence survival after upfront pancreatoduodenectomy. Nodal involvement, tumor differentiation, and postoperative chemotherapy were independent predictors of OS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00432-023-05426-2

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Kaplan–Meier curves of overall survival (OS) of patient with and without preoperative statin treatment (median OS: statin, 29 months, 95% CI 22–36 vs. no statin, 27 months, 95% CI 22–32, p = 0.370)
Fig. 1 Kaplan–Meier curves of overall survival (OS) of patient with and without preoperative statin treatment (median OS: statin, 29 months, 95% CI 22–36 vs. no statin, 27 months, 95% CI 22–32, p = 0.370)CC BY · PubMed Central
Fig. 2 Kaplan–Meier curves of disease-free survival (DFS) of patient with and without preoperative statin treatment (median DFS: statin, 18 months, 95% CI 14–22 vs. no statin, 16 months, 95% CI 14–18, p = 0.430)
Fig. 2 Kaplan–Meier curves of disease-free survival (DFS) of patient with and without preoperative statin treatment (median DFS: statin, 18 months, 95% CI 14–22 vs. no statin, 16 months, 95% CI 14–18, p = 0.430)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 7

Metadata

Authors
Joliat, G.-R., Gaspar-Figueiredo, S., Labgaa, I., Vrochides, D., Perinel, J., Adham, M., Demartines, N., & Schäfer, M.
Affiliations
  • University of Bern (CH)
  • Carolinas Medical Center (US)
  • Hôpital Edouard Herriot (FR)
  • Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Joliat, Gaëtan-Romain
Venue
Journal of Cancer Research and Clinical Oncology
Published
2023-09-23
Volume
149
Issue
19
Pages
17007-17014
ISSN
  • 0084-5353 (ISSN-L)
  • 0171-5216
  • 1432-1335
OpenAlex
W4386980322
Cited by
3
References
19
Citations by year
2026: 1 · 2025: 2
FWCI
0.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Cancer Research and Clinical Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (acceptedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
Funders
University of Lausanne
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords
statins, pancreatic ductal adenocarcinoma, pancreaticoduodenectomy, preoperative statin therapy, overall survival, disease-free survival, prognostic factors, lymph node involvement, tumor differentiation, postoperative chemotherapy, resectability, postoperative complications, postoperative mortality, long-term outcomes, predictors of recurrence, mortality risk factors, predictors of quality of life
MeSH terms
Adenocarcinoma, Adult, Aged, Cross-Sectional Studies, Female, Humans, Male, Pancreatic Neoplasms, Prognosis, Retrospective Studies, Pancreaticoduodenectomy, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Carcinoma, Pancreatic Ductal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study. https://app.cochat.ai/papers/10.1007/s00432-023-05426-2
The paper
Joliat, G.-R., Gaspar-Figueiredo, S., Labgaa, I., Vrochides, D., Perinel, J., Adham, M., Demartines, N., & Schäfer, M. (2023). Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-05426-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.